416 related articles for article (PubMed ID: 20445061)
1. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
Jowaed A; Schmitt I; Kaut O; Wüllner U
J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061
[TBL] [Abstract][Full Text] [Related]
2. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.
Matsumoto L; Takuma H; Tamaoka A; Kurisaki H; Date H; Tsuji S; Iwata A
PLoS One; 2010 Nov; 5(11):e15522. PubMed ID: 21124796
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease.
Ai SX; Xu Q; Hu YC; Song CY; Guo JF; Shen L; Wang CR; Yu RL; Yan XX; Tang BS
J Neurol Sci; 2014 Feb; 337(1-2):123-8. PubMed ID: 24326201
[TBL] [Abstract][Full Text] [Related]
5. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation levels of α-synuclein intron 1 in the aging brain.
de Boni L; Riedel L; Schmitt I; Kraus TFJ; Kaut O; Piston D; Akbarian S; Wüllner U
Neurobiol Aging; 2015 Dec; 36(12):3334.e7-3334.e11. PubMed ID: 26422361
[TBL] [Abstract][Full Text] [Related]
7. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants associated with Parkinson's disease display widespread signature of epigenetic plasticity.
Sharma A; Osato N; Liu H; Asthana S; Dakal TC; Ambrosini G; Bucher P; Schmitt I; Wüllner U
Sci Rep; 2019 Dec; 9(1):18464. PubMed ID: 31804560
[TBL] [Abstract][Full Text] [Related]
9. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population.
Wei Y; Yang N; Xu Q; Sun Q; Guo J; Li K; Liu Z; Yan X; Zhu X; Tang B
J Neurol Sci; 2016 Aug; 367():11-4. PubMed ID: 27423554
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine.
Jiang W; Li J; Zhang Z; Wang H; Wang Z
Eur J Pharmacol; 2014 Dec; 745():243-8. PubMed ID: 25445041
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with
Smith AR; Richards DM; Lunnon K; Schapira AHV; Migdalska-Richards A
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769009
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms.
Cardo LF; Coto E; de Mena L; Ribacoba R; Mata IF; Menéndez M; Moris G; Alvarez V
Neurosci Lett; 2014 Mar; 562():45-9. PubMed ID: 24418406
[TBL] [Abstract][Full Text] [Related]
13. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions.
Eryilmaz IE; Cecener G; Erer S; Egeli U; Tunca B; Zarifoglu M; Elibol B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Colakoglu B; Kenangil G; Kaleagasi H
Neurol Res; 2017 Nov; 39(11):965-972. PubMed ID: 28830306
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
16. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
[TBL] [Abstract][Full Text] [Related]
17. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.
Neystat M; Lynch T; Przedborski S; Kholodilov N; Rzhetskaya M; Burke RE
Mov Disord; 1999 May; 14(3):417-22. PubMed ID: 10348463
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
Pihlstrøm L; Berge V; Rengmark A; Toft M
Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
[TBL] [Abstract][Full Text] [Related]
20. [Neurodegeneration and epigenetics].
Iwata A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):269-73. PubMed ID: 23373314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
